Acyclovir and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Evista (raloxifene hydrochloride). Common drug interactions include contusion among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Evista. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.



On Jul, 21, 2026

54 people who take Acyclovir and Evista together, and have interactions are studied.

Acyclovir and Evista drug interactions.

What are the common drug interactions of Acyclovir and Evista, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Road traffic accident
  3. Infection
  4. General physical health deterioration (weak health status)
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Pain
  7. Fall
  8. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  9. Spinal osteoarthritis (joint cartilage loss in spine)
  10. Aphthous stomatitis (mouth ulcer)

male:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Insomnia (sleeplessness)
  4. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  5. Loose tooth
  6. Nocturia (the need to get up in the night to urinate)
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Pain
  9. Pneumonia
  10. Rib fracture

What are the common drug interactions of Acyclovir and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Adenomyosis (presence of ectopic glandular tissue found in muscle)
  3. Anaemia (lack of blood)
  4. Anxiety
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Balance disorder
  7. Bone density increased
  8. Bone disorder
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Calcinosis (calcium deposits in any soft tissue)

20-29:

n/a

30-39:

n/a

40-49:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Erythema (redness of the skin)
  3. Red blood cell sedimentation rate increased
  4. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  5. Skin lesion
  6. Asthenia (weakness)
  7. Back injury
  8. Dizziness
  9. Drug ineffective
  10. Fall

50-59:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Depression
  3. Arthralgia (joint pain)
  4. Dyspnoea (difficult or laboured respiration)
  5. Infection
  6. Abdominal pain
  7. Abscess limb (limb infection)
  8. Alopecia areata (patchy baldness that typically begins with rapid hair loss)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Atelectasis (partial or complete collapse of the lung)

60+:

  1. Anxiety
  2. Road traffic accident
  3. Infection
  4. Loose tooth
  5. Oral herpes (viral infection of mouth)
  6. Osteonecrosis (death of bone)
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Pain
  9. Temporomandibular joint syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress)
  10. Vertigo

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 12 people, 22.22%
  2. Depression: 12 people, 22.22%
  3. Sleep Disorder: 9 people, 16.67%
  4. Genital Herpes (herpes infection of genital): 9 people, 16.67%
  5. Pain: 8 people, 14.81%
  6. Hyperchlorhydria (gastric acid levels are higher in stomach): 8 people, 14.81%
  7. High Blood Pressure: 8 people, 14.81%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 14.81%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 8 people, 14.81%
  10. Affective Disorder (mental disorder): 8 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and raloxifene hydrochloride (the active ingredients of Acyclovir and Evista, respectively), and Acyclovir and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: